• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《3 型戈谢病综述:独特的神经表现及治疗进展》

A review of type 3 Gaucher disease: unique neurological manifestations and advances in treatment.

机构信息

Shaoxing University, Shaoxing, 312000, Zhejiang, China.

Department of Hematology, Shaoxing People's Hospital, 568 Zhongxing North Road, Shaoxing, 312000, Zhejiang, China.

出版信息

Acta Neurol Belg. 2024 Aug;124(4):1213-1223. doi: 10.1007/s13760-024-02493-1. Epub 2024 Feb 28.

DOI:10.1007/s13760-024-02493-1
PMID:38413480
Abstract

Gaucher disease (GD) is a rare lysosomal storage disease that is caused by mutations in the GBA gene. It is classified into three main phenotypes according to the patient's clinical presentation. Of these, chronic neuronopathic GD (GD3) is characterized by progressive neurological damage. Understanding the unique neurological manifestations of GD3 has important diagnostic and therapeutic implications. Our article summarizes the neurological symptoms specific to GD3 and related therapeutic advances, and it highlights the relevance of the gene to clinical symptoms, so as to provide a reference for the diagnosis and treatment of GD3.

摘要

戈谢病(GD)是一种罕见的溶酶体贮积病,由 GBA 基因突变引起。根据患者的临床表现,该病可分为三种主要表型。其中,慢性神经病变型 GD(GD3)的特征是进行性神经损伤。了解 GD3 的独特神经表现具有重要的诊断和治疗意义。本文总结了 GD3 的特定神经症状和相关治疗进展,并强调了基因与临床症状的相关性,以期为 GD3 的诊断和治疗提供参考。

相似文献

1
A review of type 3 Gaucher disease: unique neurological manifestations and advances in treatment.《3 型戈谢病综述:独特的神经表现及治疗进展》
Acta Neurol Belg. 2024 Aug;124(4):1213-1223. doi: 10.1007/s13760-024-02493-1. Epub 2024 Feb 28.
2
A novel mutation causing type 1 Gaucher disease found in a Japanese patient with gastric cancer: A case report.在一名日本胃癌患者中发现导致1型戈谢病的新型突变:病例报告。
Medicine (Baltimore). 2018 Jul;97(27):e11361. doi: 10.1097/MD.0000000000011361.
3
Diagnosing neuronopathic Gaucher disease: New considerations and challenges in assigning Gaucher phenotypes.诊断神经病变型戈谢病:戈谢表型分类的新考虑因素和新挑战。
Mol Genet Metab. 2021 Feb;132(2):49-58. doi: 10.1016/j.ymgme.2021.01.002. Epub 2021 Jan 9.
4
Gaucher disease: the metabolic defect, pathophysiology, phenotypes and natural history.戈谢病:代谢缺陷、病理生理学、表型及自然史
Pediatr Endocrinol Rev. 2014 Sep;12 Suppl 1(0 1):72-81.
5
Long-term hematological, visceral, and growth outcomes in children with Gaucher disease type 3 treated with imiglucerase in the International Collaborative Gaucher Group Gaucher Registry.国际协作戈谢病研究组戈谢病登记处中接受伊米苷酶治疗的3型戈谢病患儿的长期血液学、内脏及生长转归
Mol Genet Metab. 2017 Jan-Feb;120(1-2):47-56. doi: 10.1016/j.ymgme.2016.12.001. Epub 2016 Dec 6.
6
Viral delivery of a microRNA to Gba to the mouse central nervous system models neuronopathic Gaucher disease.病毒向小鼠中枢神经系统中的 Gba 传递 microRNA 可模拟神经病变型 Gaucher 病。
Neurobiol Dis. 2019 Oct;130:104513. doi: 10.1016/j.nbd.2019.104513. Epub 2019 Jun 21.
7
Gaucher Disease: Clinical, Biological and Therapeutic Aspects.戈谢病:临床、生物学及治疗方面
Pathobiology. 2016;83(1):13-23. doi: 10.1159/000440865. Epub 2015 Nov 21.
8
Gaucher disease type 3c: New patients with unique presentations and review of the literature.戈谢病 3c 型:具有独特表现的新患者及文献复习。
Mol Genet Metab. 2019 Jun;127(2):138-146. doi: 10.1016/j.ymgme.2019.05.011. Epub 2019 May 21.
9
Hematopoietic stem cell transplantation or enzyme replacement therapy in Gaucher disease type 3.戈谢病3型的造血干细胞移植或酶替代疗法。
Mol Genet Metab. 2024 Aug;142(4):108515. doi: 10.1016/j.ymgme.2024.108515. Epub 2024 Jun 13.
10
The clinical management of Type 2 Gaucher disease.2型戈谢病的临床管理
Mol Genet Metab. 2015 Feb;114(2):110-122. doi: 10.1016/j.ymgme.2014.11.008. Epub 2014 Nov 14.

引用本文的文献

1
Clinical Outcomes and Genetic Mutations in Turkish Patients with Type 1 Gaucher Disease: Insights from a Single-Center Study.土耳其1型戈谢病患者的临床结局与基因突变:一项单中心研究的见解
J Pers Med. 2025 Mar 12;15(3):109. doi: 10.3390/jpm15030109.

本文引用的文献

1
The Spectrum of Neurological and Sensory Abnormalities in Gaucher Disease Patients: A Multidisciplinary Study (SENOPRO).《戈谢病患者神经系统和感觉异常的范围:一项多学科研究(SENOPRO)》。
Int J Mol Sci. 2023 May 16;24(10):8844. doi: 10.3390/ijms24108844.
2
Global Incidence and Prevalence of Gaucher Disease: A Targeted Literature Review.戈谢病的全球发病率和患病率:一项针对性文献综述。
J Clin Med. 2022 Dec 22;12(1):85. doi: 10.3390/jcm12010085.
3
Exploring the link between GBA1 mutations and Dementia with Lewy bodies, A mini-review.
探讨 GBA1 突变与路易体痴呆之间的联系,一篇迷你综述。
Neurosci Biobehav Rev. 2022 Oct;141:104856. doi: 10.1016/j.neubiorev.2022.104856. Epub 2022 Sep 6.
4
Thirty-year clinical outcomes after haematopoietic stem cell transplantation in neuronopathic Gaucher disease.神经病变型戈谢病患者行造血干细胞移植后 30 年的临床转归
Orphanet J Rare Dis. 2022 Jun 18;17(1):234. doi: 10.1186/s13023-022-02378-7.
5
Neuropathological Features of Gaucher Disease and Gaucher Disease with Parkinsonism.戈谢氏病和帕金森病伴发戈谢氏病的神经病理学特征。
Int J Mol Sci. 2022 May 23;23(10):5842. doi: 10.3390/ijms23105842.
6
The diagnosis and management of Gaucher disease in pediatric patients: Where do we go from here?儿童戈谢病的诊断与管理:我们从这里何去何从?
Mol Genet Metab. 2022 May;136(1):4-21. doi: 10.1016/j.ymgme.2022.03.001. Epub 2022 Mar 9.
7
Early initiation of ambroxol treatment diminishes neurological manifestations of type 3 Gaucher disease: A long-term outcome of two siblings.早期启动氨溴索治疗可减轻 3 型戈谢病的神经表现:两例同胞的长期结局。
Eur J Paediatr Neurol. 2021 May;32:66-72. doi: 10.1016/j.ejpn.2021.03.013. Epub 2021 Mar 31.
8
Hematological manifestations and complications of Gaucher disease.戈谢病的血液学表现和并发症。
Expert Rev Hematol. 2021 Apr;14(4):347-354. doi: 10.1080/17474086.2021.1908120. Epub 2021 Mar 31.
9
Diagnosing neuronopathic Gaucher disease: New considerations and challenges in assigning Gaucher phenotypes.诊断神经病变型戈谢病:戈谢表型分类的新考虑因素和新挑战。
Mol Genet Metab. 2021 Feb;132(2):49-58. doi: 10.1016/j.ymgme.2021.01.002. Epub 2021 Jan 9.
10
Spectrum of movement disorders in GNAO1 encephalopathy: in-depth phenotyping and case-by-case analysis.GNAO1 脑病的运动障碍谱:深入表型分析和逐个病例分析。
Orphanet J Rare Dis. 2020 Dec 9;15(1):343. doi: 10.1186/s13023-020-01594-3.